• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Finding investigators and patients for faster trials

Finding investigators and patients for faster trials

April 15, 2016
CenterWatch Staff

In the January issue of The CenterWatch Monthly, I wrote about using insurance claims and electronic health records (EHR) to understand patient availability for clinical trials. Combined, these sources can tell you if enough patients meet the criteria, enabling redesign and better planning.

Once you know the patients are out there, how do you find them? Traditionally, sponsors send feasibility questionnaires to prospective investigators. Estimated patient counts are infamous for being too high. It is no wonder that Tufts data shows that only 38% of sites meet their enrollment targets. Consequently 94% of studies must increase their enrollment timeline to meet targets.

Hiring investigators who have enrolled well previously may ensure quality, but not necessarily the quantity. I recommend these two objective methods.

First, identify the geographic areas with the highest concentrations of patients who satisfy your trial protocol. Good prevalence projections use the inclusion/exclusion criteria. For example, suppose a trial needed diabetics without hypertension. The national prevalence of those who present for treatment is 2.2% of adults. This is lower than you might expect, because three-fourths of diabetics have hypertension, and we just excluded them. The city with the greatest recruitment opportunity for a trial, and perhaps a vacation, is Honolulu, with 3.8%. (Source: Optum insurance claims.)

Second, create a national investigator list, ranked by the number of patients who qualify. Insurance claims have this information as well. For the diabetics without hypertension, there are about 17,000 treating investigators in the U.S., out of about 130,000 active ones with experience. The top one is a group practice, with 254 qualifying patients in the past year.

Everyone says fish where the fish are, but do you have a fish finder? If you lack tools to find investigators with patients, it might be time to reconsider.

 

Written by Guest Writer Bill Gwinn. Gwinn is Vice President of Clinical Informatics Solutions at Optum, a subsidiary of UnitedHealth Group, a diversified managed health care company. Bill supports the clinical trials of new drugs with medical statistics. His expertise lies in quantitative analysis for site selection and finding patients. Prior positions include the Medstat Group at Thomson Reuters, IMS Health, Schering-Plough, and Procter & Gamble. Bill holds an MBA from the University of Chicago and a BA from Vanderbilt University. www.optum.com.

This article was reprinted from Volume 23, Issue 04, of The CenterWatch Monthly, an industry leading publication providing hard-hitting, authoritative business and financial coverage of the clinical research space. The Action Items section features short columns  focusing on actionable or how-to advice from clinical trial professionals. To submit an Action Item, please contact editorial@centerwatch.com. Subscribe >>

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing